Literature DB >> 24651735

Association between maternal inflammatory bowel disease and adverse perinatal outcomes.

D Getahun1, M J Fassett2, G F Longstreth3, C Koebnick3, A M Langer-Gould3, D Strickland3, S J Jacobsen3.   

Abstract

OBJECTIVE: To examine whether inflammatory bowel disease (IBD) is associated with ischemic/inflammatory conditions during pregnancy. STUDY
DESIGN: A retrospective cohort study using the 2000 to 2012 Kaiser Permanente Southern California maternally-linked medical records (n=395 781). The two major subtypes of IBD, ulcerative colitis and Crohn's diseases were studied. Adjusted odds ratios (ORs) were used to quantify the associations. RESULT: A pregnancy complicated by IBD was associated with increased incidence of small-for-gestational age birth (OR=1.46, 95% confidence interval (CI)=1.14 to 1.88), spontaneous preterm birth (OR=1.32, 95% CI=1.00 to 1.76) and preterm premature rupture of membranes (OR=1.95, 95% CI=1.26 to 3.02). Further stratifying by IBD subtypes, only ulcerative colitis was significantly associated with increased incidence of ischemic placental disease, spontaneous preterm birth and preterm premature rupture of membranes.
CONCLUSION: The findings underscore the potential impact of maternal IBD on adverse perinatal outcomes. Clinicians should be aware that the association between IBD and adverse perinatal outcome varies by IBD subtypes.

Entities:  

Mesh:

Year:  2014        PMID: 24651735     DOI: 10.1038/jp.2014.41

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   2.521


  36 in total

1.  Perinatal outcomes in inflammatory bowel disease.

Authors:  M C Bush; S Patel; R H Lapinski; J L Stone
Journal:  J Matern Fetal Neonatal Med       Date:  2004-04

Review 2.  Breastfeeding and risk of inflammatory bowel disease: a systematic review with meta-analysis.

Authors:  Eyal Klement; Regev V Cohen; Jonathan Boxman; Aviva Joseph; Shimon Reif
Journal:  Am J Clin Nutr       Date:  2004-11       Impact factor: 7.045

3.  The epidemiology of inflammatory bowel disease in Canada: a population-based study.

Authors:  Charles N Bernstein; Andre Wajda; Lawrence W Svenson; Adrian MacKenzie; Mieke Koehoorn; Maureen Jackson; Richard Fedorak; David Israel; James F Blanchard
Journal:  Am J Gastroenterol       Date:  2006-07       Impact factor: 10.864

4.  Time trends in therapies and outcomes for adult inflammatory bowel disease, Northern California, 1998-2005.

Authors:  Lisa J Herrinton; Liyan Liu; Bruce Fireman; James D Lewis; James E Allison; Nicole Flowers; Susan Hutfless; Fernando S Velayos; Oren Abramson; Andrea Altschuler; Geraldine S Perry
Journal:  Gastroenterology       Date:  2009-05-13       Impact factor: 22.682

5.  Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD).

Authors:  S Shivananda; J Lennard-Jones; R Logan; N Fear; A Price; L Carpenter; M van Blankenstein
Journal:  Gut       Date:  1996-11       Impact factor: 23.059

6.  Chronic inflammatory bowel disease, cigarette smoking, and use of oral contraceptives: findings in a large cohort study of women of childbearing age.

Authors:  M Vessey; D Jewell; A Smith; D Yeates; K McPherson
Journal:  Br Med J (Clin Res Ed)       Date:  1986-04-26

7.  Crohn's disease after in-utero measles virus exposure.

Authors:  A Ekbom; P Daszak; W Kraaz; A J Wakefield
Journal:  Lancet       Date:  1996-08-24       Impact factor: 79.321

8.  The effect on the fetus of medications used to treat pregnant inflammatory bowel-disease patients.

Authors:  David Norman Moskovitz; Carol Bodian; Mark L Chapman; James F Marion; Peter H Rubin; Ellen Scherl; Daniel H Present
Journal:  Am J Gastroenterol       Date:  2004-04       Impact factor: 10.864

Review 9.  Aberrant homing of mucosal T cells and extra-intestinal manifestations of inflammatory bowel disease.

Authors:  David H Adams; Bertus Eksteen
Journal:  Nat Rev Immunol       Date:  2006-03       Impact factor: 53.106

10.  Primary preeclampsia in the second pregnancy: effects of changes in prepregnancy body mass index between pregnancies.

Authors:  Darios Getahun; Cande V Ananth; Yinka Oyelese; Martin R Chavez; Russell S Kirby; John C Smulian
Journal:  Obstet Gynecol       Date:  2007-12       Impact factor: 7.623

View more
  12 in total

Review 1.  Managing IBD Therapies in Pregnancy.

Authors:  Jill K J Gaidos; Sunanda V Kane
Journal:  Curr Treat Options Gastroenterol       Date:  2017-03

2.  A free terminal ileal perforation from active crohn disease in pregnancy: a diagnostic challenge.

Authors:  Sunu Philip; Armin Kamyab; Paraskevi Orfanou
Journal:  Int Surg       Date:  2015-03

3.  Obstetric and neonatal complications among women with autoimmune disease.

Authors:  Andrew Williams; Katherine Grantz; Indulaxmi Seeni; Candace Robledo; Shanshan Li; Marion Ouidir; Carrie Nobles; Pauline Mendola
Journal:  J Autoimmun       Date:  2019-05-27       Impact factor: 7.094

4.  Inflammatory bowel disease in pregnancy: Developing a multidisciplinary care pathway in East London.

Authors:  Mandeep K Kaler; Madeleine Malina; Klaartje Kok; Rehan Khan
Journal:  Obstet Med       Date:  2021-05-06

5.  The Effects of Active IBD During Pregnancy in the Era of Novel IBD Therapies.

Authors:  Alison de Lima-Karagiannis; Zuzana Zelinkova-Detkova; Christien Janneke van der Woude
Journal:  Am J Gastroenterol       Date:  2016-06-28       Impact factor: 10.864

6.  Pharmacokinetics of monoclonal antibodies used for inflammatory bowel diseases in pregnant women.

Authors:  Rebecca H Stone; James Hong; Hyunyoung Jeong
Journal:  J Clin Toxicol       Date:  2014-08-25

7.  Growth modeling of the maternal cytokine milieu throughout normal pregnancy: macrophage-derived chemokine decreases as inflammation/counterregulation increases.

Authors:  Shernan G Holtan; Yiyi Chen; Rajani Kaimal; Douglas J Creedon; Elizabeth Ann L Enninga; Wendy K Nevala; Svetomir N Markovic
Journal:  J Immunol Res       Date:  2015-03-17       Impact factor: 4.818

8.  Mutations in fetal genes involved in innate immunity and host defense against microbes increase risk of preterm premature rupture of membranes (PPROM).

Authors:  Bhavi P Modi; Maria E Teves; Laurel N Pearson; Hardik I Parikh; Hannah Haymond-Thornburg; John L Tucker; Piya Chaemsaithong; Nardhy Gomez-Lopez; Timothy P York; Roberto Romero; Jerome F Strauss
Journal:  Mol Genet Genomic Med       Date:  2017-08-23       Impact factor: 2.183

9.  Maternal inflammatory bowel disease and hypospadias in male offspring: a population-based study in Denmark.

Authors:  Ane Birgitte Telén Andersen; Vera Ehrenstein; Rune Erichsen; Trine Frøslev; Henrik Toft Sørensen
Journal:  BMJ Open Gastroenterol       Date:  2016-11-10

10.  Intraventricular Hemorrhage Due to Coagulopathy After Vitamin K Administration in a Preterm Infant With Maternal Crohn Disease.

Authors:  Kazumichi Fujioka; Sachiyo Fukushima; Kosuke Nishida; Kazumoto Iijima; Ichiro Morioka
Journal:  Jpn Clin Med       Date:  2017-12-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.